AUGUST 5, 2019

To read this full article you need to be subscribed to Newsline.

Sign in Sign up for a FREE subscription

Thor Equities launches new life sciences platform

by Andrea Zander

Thor Equities has created Thor Sciences, a division specializing in the life sciences sector.

It comes on the heels of Thor’s $152 million acquisition of The Center of Excellence, a 784,000-square-foot campus that spans 48 acres located in Bridgewater, New Jersey. Comprised of laboratory, research and development, and office buildings, the complex features life science companies specializing in pharmaceuticals and health services including anchor tenants Nestlé Health Science, Ashland, and Amneal Pharmaceuticals. Additional tenants include Insmed, Avantor, Nevakar, Solaris Pharma, Clinical Genomics, Matinas BioPharma, Vertice Pharma, 3D Biotek, Unionmed Tech and GSG Scientific. Expansion plans for The Center of Excellence are expected to be in excess of tens of millions of dollars.

“We are pleased to announce the launch

Forgot your username or password?